Skip to main content
Top
Published in:

26-12-2023 | Testosterone | Original Article

Evaluation of CRP/Albumin Ratio in Polycystic Ovarian Syndrome

Authors: Nandini Upadhyay, Edelbert Anthonio Almeida, Alpana Singh, S. V. Madhu, Dinesh Puri, Mohit Mehndiratta

Published in: The Journal of Obstetrics and Gynecology of India | Issue 2/2024

Login to get access

Abstract

Background

Polycystic ovarian syndrome is a common endocrine disorder among women of reproductive age. It is characterized by menstrual abnormalities, hyperandrogenism and polycystic ovaries and can lead to many complications. Studies have postulated the role of inflammation in the pathophysiology of PCOS. As acute phase reactants often serve as markers of inflammation, this study aimed to evaluate the role of inflammatory markers in women with PCOS and healthy controls.

Material and Methods

A total of 60 participants were enrolled; 30 cases of PCOS and 30 age matched healthy controls. Peripheral venous blood was collected for assessment of CRP, serum albumin, serum total testosterone, serum fasting insulin and fasting blood glucose, following which statistical analysis was done.

Results

The CRP/albumin ratio was found to be significantly higher in women with PCOS as compared to healthy controls along with serum total testosterone and HOMA-IR. Correlation between CRP/albumin ratio and the levels of serum total testosterone and insulin resistance was found to be non-significant.

Conclusion

An elevated CRP/albumin ratio in cases of PCOS compared to healthy controls supports the hypothesis of inflammation playing a key role in the pathophysiology of PCOS. CRP/albumin ratio can serve as a cheaper biochemical marker of the disease subject to further validation studies to establish its use in Indian population.
Literature
1.
go back to reference Macut D, Bjekić-Macut J, Rahelić D, Doknić M, et al. Insulin and the polycystic ovary syndrome. Diabet Res Clin Pract. 2017;130:163–70.CrossRef Macut D, Bjekić-Macut J, Rahelić D, Doknić M, et al. Insulin and the polycystic ovary syndrome. Diabet Res Clin Pract. 2017;130:163–70.CrossRef
2.
go back to reference Ganie MA, Vasudevan V, Wani IA, et al. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150(4):333–44.CrossRefPubMedPubMedCentral Ganie MA, Vasudevan V, Wani IA, et al. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150(4):333–44.CrossRefPubMedPubMedCentral
3.
go back to reference Nandi A, Chen Z, Patel R, et al. Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2014;43(1):123–47.CrossRefPubMed Nandi A, Chen Z, Patel R, et al. Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2014;43(1):123–47.CrossRefPubMed
5.
go back to reference Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–5.CrossRefPubMed Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–5.CrossRefPubMed
8.
go back to reference Kalyan S, Goshtesabi A, Sarray S, et al. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics. BMJ Open. 2018;8(10): e021860.CrossRefPubMedPubMedCentral Kalyan S, Goshtesabi A, Sarray S, et al. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics. BMJ Open. 2018;8(10): e021860.CrossRefPubMedPubMedCentral
9.
go back to reference Smet ME, McLennan A. Rotterdam criteria, the end. Aust J Ultrasound Med. 2018;21(2):59–60.CrossRef Smet ME, McLennan A. Rotterdam criteria, the end. Aust J Ultrasound Med. 2018;21(2):59–60.CrossRef
11.
go back to reference González F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300–5.CrossRefPubMed González F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300–5.CrossRefPubMed
12.
go back to reference Boulman N, Levy Y, Leiba R, et al. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab. 2004;89(5):2160–5.CrossRefPubMed Boulman N, Levy Y, Leiba R, et al. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab. 2004;89(5):2160–5.CrossRefPubMed
13.
go back to reference Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020;31(2):130–6.CrossRefPubMed Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020;31(2):130–6.CrossRefPubMed
14.
go back to reference Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(3):803–10.CrossRefPubMed Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(3):803–10.CrossRefPubMed
15.
go back to reference Zhou T, Zhan J, Hong S, et al. Ratio of C-reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep. 2015;5:10481.CrossRefPubMedPubMedCentral Zhou T, Zhan J, Hong S, et al. Ratio of C-reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep. 2015;5:10481.CrossRefPubMedPubMedCentral
16.
go back to reference Barth JH, Field HP, Yasmin E, et al. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography–tandem mass spectrometry and analysis by receiver operator characteristic plots. Eur J Endocrinol. 2010;162(3):611–5.CrossRefPubMed Barth JH, Field HP, Yasmin E, et al. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography–tandem mass spectrometry and analysis by receiver operator characteristic plots. Eur J Endocrinol. 2010;162(3):611–5.CrossRefPubMed
Metadata
Title
Evaluation of CRP/Albumin Ratio in Polycystic Ovarian Syndrome
Authors
Nandini Upadhyay
Edelbert Anthonio Almeida
Alpana Singh
S. V. Madhu
Dinesh Puri
Mohit Mehndiratta
Publication date
26-12-2023
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue 2/2024
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-023-01897-y

Other articles of this Issue 2/2024

The Journal of Obstetrics and Gynecology of India 2/2024 Go to the issue